.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Max Healthcare Institute Ltd has officially joined an international research consortium under the Indo-EU COMBAT initiative. This dengue research initiative aims to strengthen global preparedness for mosquito-borne diseases. Supported by the Department of Biotechnology and the European Commission, the project brings together elite institutions from India and Europe. Consequently, they aim to develop technology-driven approaches for understanding, diagnosing, and managing dengue.
The consortium secured a major research grant to study disease progression. Specifically, researchers will focus on identifying early warning markers to improve patient outcomes. Representing Max Healthcare are principal investigators Sandeep Budhiraja and Atul Thatai. Furthermore, Ujjwal Neogi from the Karolinska Institute facilitated this collaboration. The BRIC National Institute of Biomedical Genomics leads the Indian effort. Because dengue remains a significant health concern, this project integrates multi-omics technologies and artificial intelligence. This combination helps researchers identify predictive biomarkers for earlier diagnosis.
Dengue continues to pose a major public health challenge in tropical regions. Therefore, partnerships that combine clinical expertise with advanced research are essential. Dr. Budhiraja noted that these collaborations strengthen early diagnosis and improve patient response strategies. Similarly, Dr. Neogi highlighted the importance of data-driven solutions. Moreover, these innovations help build stronger surveillance and treatment frameworks. As a result, the initiative advances global pandemic preparedness through cross-border scientific cooperation.
Q1: What is the primary goal of the Indo-EU COMBAT initiative?
The primary goal is to strengthen dengue research and improve global preparedness for mosquito-borne diseases through collaborative research and technology-driven approaches.
Q2: How will multi-omics and AI be used in this research?
The program will combine multi-omics technologies, clinical data, and artificial intelligence to better understand how dengue progresses and identify predictive biomarkers for earlier clinical interventions.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Max Healthcare joins Indo-EU COMBAT initiative to advance dengue research using multi-omics and AI for early diagnosis and better patient outcomes....
4 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
